[Temporary Announcement] Huayi Taikang: 2025 Annual Work Report of Independent Directors
Announcement number: 2026-083
Securities code: 874191 Securities abbreviation: Huayi Taikang Sponsored securities firm: Guolian Minsheng Underwriting Sponsor Huayi Taikang Pharmaceutical Co., Ltd.
Independent Directors’ 2025 Annual Work Report
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.
As independent directors of Huayitaikang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), Wei Feijun, Tian Shuguang, Zhuan Lei and Zong Chengli strictly followed the provisions of the "Company Law", "Company Articles" and "National Small and Medium Enterprises Equities Exchange and Quotations Company Governance Guidelines No. 2 - Independent Directors" during their tenure. They performed their duties conscientiously, diligently and prudently, actively attended relevant meetings, carefully reviewed various proposals, and completed various tasks assigned by the board of directors. The report on the performance of independent directors’ duties in 2025 is as follows:
1. Basic information about independent directors
In order to further improve the corporate governance structure, promote the company's standardized operations, and establish a more complete legal person governance structure, in accordance with the provisions of laws, regulations, and normative documents such as the "Company Law", "Company Articles of Association", "National Small and Medium-sized Enterprises Equities Exchange and Quotations Company Governance Guidelines No. 2 - Independent Directors", the company was nominated by the company's board of directors and held on August 14, 2025. At the third extraordinary shareholders' meeting in 2017, Wei Feijun, Tian Shuguang, Zhuan Lei and Zong Chengli were elected as the new independent directors of the company's second board of directors.
(1) Work history, professional background and part-time employment status
Wei Feijun, Chinese nationality, no right of abode abroad, male, born in October 1966, graduated from Hangzhou University with a bachelor's degree, senior accountant, senior economist, certified tax accountant, and Executive Master of Business Administration (EMBA) from Hong Kong Asia Business School. He has served as the legal representative of Haikou Zhengda Guangming Tax Agency Co., Ltd., and currently serves as the legal representative of Hainan Dahua Guangming Tax Agency (General Partnership) and the vice president of the Hainan Association of Chief Accountants. From July 2021 to the present, he has served as the independent director of Hainan Haiqi Transportation Group Co., Ltd., and from August 2025 to the present, he has served as the independent director of Huayi Taikang.
Tian Shuguang, Chinese nationality, no right of residence abroad, male, born in September 1969, graduated from Zhongnan University of Finance and Economics with a bachelor's degree, and is a Chinese certified public accountant, senior accountant, and senior international financial manager. Served successively
Announcement number: 2026-083
Chief accountant and chief partner of Shenzhen Sanwei Accounting Firm, director of internal control and internal audit and financial director of Shenzhen Huada Gene Technology Co., Ltd. Currently, he is a certified public accountant and business partner of Pengsheng Accounting Firm (Special General Partnership). From August 2025 to present, he serves as an independent director of Huayi Taikang.
Zhuan Lei, Chinese nationality, no right of residence abroad, male, born in September 1980, graduated from Zhongnan University of Economics and Law. Hainan Province's first batch of administrative law professional lawyers, currently an unlimited partner of Guoco Law Firm (Hainan), deputy director of the Administrative Professional Committee of Hainan Lawyers Association, Hainan Province budget performance management expert, Hainan International Arbitration Court arbitrator, legislative consulting expert of the Standing Committee of the 16th Danzhou City People's Congress, and Haikou City administrative review consulting expert. From August 2025 to January 2026, he served as an independent director of Huayitaikang.
Zong Chengli, Chinese nationality, no right of abode abroad, male, born in September 1984, graduated from the University of Georgia, doctoral degree, professor, doctoral supervisor. He has served as a senior scientist at Merck & Co., Ltd., and is currently a professor at the School of Pharmacy at Hainan University. From August 2025 to present, he serves as an independent director of Huayitaikang.
(2) Whether there is any explanation that affects independence
During their tenure as independent directors of the company, Wei Feijun, Tian Shuguang, Zhuo Lei and Zong Chengli did not hold any position in the company other than independent directors, nor did they hold any position in the company's major shareholder company. There was no relationship that might hinder their independent and objective judgment, and there was no situation that affected the independence of independent directors. Wei Feijun, Tian Shuguang, Zhuan Lei, and Zong Chengli comply with the independence requirements required by laws, regulations, normative documents such as the Company Law, the Articles of Association, and the National Equities Exchange and Quotations Listed Company Governance Guidelines No. 2 - Independent Directors, and their qualifications to serve as independent directors of the company. They can ensure objective and independent professional judgment, and there are no circumstances that affect independence.
2. Meeting attendance
In 2025, the company held a total of 10 board meetings and 5 shareholders' meetings. The attendance of independent directors Wei Feijun, Tian Shuguang, Zhuan Lei and Zong Chengli at the meeting is as follows:
Absence Is there three consecutive times
Should attend on-site or through entrustment to attend
Directors did not attend in person or
Independent directors attend the voting of the board of directors directors shareholders
The meeting was continued for two consecutive times and I was unable to attend.
Name of director Number of meetings Number of meetings attended by the board of directors Do not entrust other directors to attend
Number of meetings Number of meetings
Number of seats
Announcement number: 2026-083
Wei Feijun 5 5 0 0 No 0 Tian Shuguang 5 5 0 0 No 0 Zhuan Lei 5 5 0 0 No 0 Zong Chengli 5 5 0 0 No 1
The company's board of directors has four special committees, namely: Audit Committee, Strategy Committee, Nomination Committee, and Remuneration and Appraisal Committee.
(1) During the performance of duties in 2025, the independent directors’ service status on special committees is as follows:
Wei Feijun serves as the convener of the Audit Committee and a member of the Remuneration and Appraisal Committee;
Tian Shuguang serves as the convenor of the Remuneration and Assessment Committee, member of the Audit Committee, and member of the Nomination Committee;
Zhuan Lei serves as the convener of the Nomination Committee and a member of the Audit Committee;
Zong Chengli serves as a member of the Strategy Committee, the Nomination Committee, and the Remuneration and Appraisal Committee.
(2) In 2025, the meetings of the special committees of the Board of Directors will be held as follows:
The Audit Committee held 3 meetings. Independent directors Wei Feijun, Tian Shuguang, and Zhuan Lei attended 3 Audit Committee meetings in person, entrusted others to attend 0 times, and were absent 0 times;
The Nomination Committee meeting was held once; independent directors Zhuo Lei, Tian Shuguang and Zong Chengli attended the Nomination Committee meeting in person once, entrusted others to attend 0 times, and were absent 0 times;
Convened 0 strategic committee meetings;
Convened 0 meetings of the Remuneration and Appraisal Committee.
3. Expression of independent opinions
Independent director Wei Feijun carefully understood and examined the company's operating activities in 2025, and issued a total of 3 independent opinions. The details are as follows:
Meeting time Meeting name Specific matters Type of opinion 2025 8 Second session of the Board of Directors 1. Agree on the <2025 Semi-annual Report>
Proposal of the seventh meeting on March 25th
- "Proposal on Provision for Asset Impairment Losses"
case"
October 2025 The second session of the Board of Directors 1. Agreement on the <Third Quarter Report of 2025>
Announcement number: 2026-083
Proposal of the Ninth Meeting on March 30th
- "Proposal on Provision for Asset Impairment Losses"
case"
December 2025 The second session of the Board of Directors 1. "Proposal on the expected daily related transactions in 2026" The tenth meeting on December 30, 2025
- "About Nomination of Independent Directors to the Company's Board of Directors"
Candidate's Bill
Independent director Tian Shuguang carefully understood and examined the company's operating activities in 2025, and issued a total of 3 independent opinions. The details are as follows:
Meeting time Meeting name Specific matters Opinion type 2025 8 Second session of the Board of Directors 1. "Proposal for the seventh meeting of the 2025 Semi-annual Report on the 25th of the month"
- "Proposal on Provision for Asset Impairment Losses"
case"
October 2025 The second session of the Board of Directors 1. "Proposal of the Ninth Meeting on the 30th of October 2025 Regarding the Third Quarterly Report of 2025"
- "Proposal on Provision for Asset Impairment Losses"
case"
December 2025 The second session of the Board of Directors 1. "Proposal on the expected daily related transactions in 2026" The tenth meeting on December 30, 2025
- "About Nomination of Independent Directors to the Company's Board of Directors"
Candidate's Bill
Independent director Zhuo Lei carefully understood and examined the company's operating activities in 2025, and issued a total of 3 independent opinions. The details are as follows:
Meeting time Meeting name Specific matters Opinion type 2025 8 Second session of the Board of Directors 1. "Proposal for the seventh meeting of the 2025 Semi-annual Report on the 25th of the month"
Announcement number: 2026-083
- "Proposal on Provision for Asset Impairment Losses"
case"
October 2025 The second session of the Board of Directors 1. "Proposal of the Ninth Meeting on the 30th of October 2025 Regarding the Third Quarterly Report of 2025"
- "Proposal on Provision for Asset Impairment Losses"
case"
December 2025 The second session of the Board of Directors 1. "Proposal on the expected daily related transactions in 2026" The tenth meeting on December 30, 2025
- "About Nomination of Independent Directors to the Company's Board of Directors"
Candidate's Bill
Independent director Zong Chengli carefully understood and examined the company's operating activities in 2025, and issued a total of 3 independent opinions. The details are as follows:
Meeting time Meeting name Specific matters Opinion type 2025 8 Second session of the Board of Directors 1. "Proposal for the seventh meeting of the 2025 Semi-annual Report on the 25th of the month"
- "Proposal on Provision for Asset Impairment Losses"
case"
October 2025 The second session of the Board of Directors 1. "Proposal of the Ninth Meeting on the 30th of October 2025 Regarding the Third Quarterly Report of 2025"
- "Proposal on Provision for Asset Impairment Losses"
case"
December 2025 The second session of the Board of Directors 1. "Proposal on the expected daily related transactions in 2026" The tenth meeting on December 30, 2025
- "About Nomination of Independent Directors to the Company's Board of Directors"
Candidate's Bill
4. Performance of special powers of independent directors
During the performance period of 2025, there were no independent directors who proposed convening a board of directors or submitted any proposals to the board of directors.
Announcement number: 2026-083
Convening extraordinary shareholders' meetings, proposing to hire or dismiss accounting firms, independently hiring external audit agencies and consulting agencies, conducting on-site inspections, etc.
5. Other situations that need explanation
Since we became independent directors of the company, the company has provided us with the necessary working conditions to perform our duties, actively supported and cooperated with our work, and has not hindered the independent directors from performing their duties. At work, we actively perform the duties of independent directors, proactively understand the company's relevant operating conditions and the progress of major events, pay attention to the implementation of resolutions of the board of directors and shareholders' meetings, make full use of the professional knowledge of independent directors, and play an independent role.
In 2026, we will continue to uphold the principles of independence, objectivity and fairness, fulfill our duties diligently and conscientiously, effectively perform the various responsibilities of independent directors, continue to strictly abide by relevant laws and regulations and the provisions of the Articles of Association, ensure the standardization and scientificization of corporate governance, promote the company to achieve high-quality development, and effectively safeguard the legitimate rights and interests of the company and all shareholders.
Independent directors: Wei Feijun, Tian Shuguang, Zhuan Lei, Zong Chengli
April 28, 2026